Home ⟩ Insights

Insights

fda

3 min read • September 24, 2024

DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling

5 min read • August 28, 2024

Cannabis And Psychedelics Industries: Summer’s Over, Where Are We?

2 min read • August 22, 2024

Bright Green To Supply DEA-Approved Cannabis Extracts And Psychedelics To FDA-Registered Pharmaceutical Company

2 min read • August 2, 2024

Cannabis Pharmaceuticals: Company With Ties To Groundbreaking Medical Developments Pursues Cannabinoid-Based Medicines

3 min read • July 24, 2024

Harris Vs. Trump: Will Cannabis Rescheduling Survive Biden’s Exit? Analyst On Potential GOP Victory

3 min read • July 11, 2024

Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US

3 min read • June 18, 2024

What Is The Trump Factor? Justice Dept’s Impact On Cannabis Rescheduling, Stocks And Investments

3 min read • June 13, 2024

Over 400 Physicians And Medical Experts Demand U.S. Gov Fully Deschedule Cannabis, Citing Insufficiency Of Rescheduling

2 min read • June 11, 2024

DEA Vs. Biden, FDA & Health Agency Over Cannabis Rescheduling: What’s Up With That?

3 min read • May 31, 2024

From Prohibition To Protection: Could Marijuana’s Reclassification Unleash A Surge In Trademark Filings?

5 min read • May 28, 2024

California’s Famous Cannabis Goes To Europe: Rescheduling Drives Demand For De-Risked, Pest-Free, Low-Cost Plants

4 min read • May 23, 2024

How Will Cannabis Rescheduling Impact Commercial Real Estate

Latest Headlines

2 min read • June 2, 2026

Vireo Growth Reshapes Share Structure After Major Expansion Transactions

2 min read • June 2, 2026

Cannabis Giant, Verano, Joins Industry Peers In Reverse Stock Split Trend With 1-For-5 Consolidation

7 min read • June 2, 2026

Cannabis M&A Is Back, But Not The Way Investors Expected

4 min read • June 2, 2026

EXCLUSIVE: Virginia Governor Defends Cannabis Veto, Citing Timeline And Licensing Concerns

2 min read • June 1, 2026

Five-Month Hemp Enforcement Grace Period Ends In Oregon, Here’s What Businesses Must Know

3 min read • June 1, 2026

New Tennessee Hemp Rules Threaten THCa Market And Millions Of Dollars In Sales

3 min read • June 1, 2026

Robinhood Opens The Door To U.S. Cannabis Stocks

4 min read • June 1, 2026

Fireman Entrepreneur Award Builds Momentum Ahead of 2026 Announcement in Chicago

4 min read • June 1, 2026

Thin Legal Challenge from State AGs Could Still Complicate Federal Cannabis Rescheduling Effort

2 min read • May 29, 2026

Canopy Growth Bets On Europe As It Relaunches This Legacy Brand in Germany’s $1B Medical Cannabis Market

2 min read • May 29, 2026

Minnesota’s New Cannabis Bill Reshapes Market For Medical And Rec Operators

2 min read • May 28, 2026

New Study Tracks How Cannabis Beverages Are Replacing Alcohol In Everyday Settings

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

hemp legalization

hemp regulation

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.